In case of SIRT3 (p = 0.03), HIF1α (p = 0.03) and PARP1 (p = 0.02) gene, significant upregulated expression was observed in glioma patients compared to control samples as shown in Fig 1A and 1C. This evidence concerns the gene PARP1 and central nervous system cancer.